Hennion & Walsh Asset Management Inc. Has $277,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Hennion & Walsh Asset Management Inc. trimmed its position in Humana Inc. (NYSE:HUM) by 38.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,091 shares of the insurance provider’s stock after selling 683 shares during the quarter. Hennion & Walsh Asset Management Inc.’s holdings in Humana were worth $277,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV raised its stake in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in shares of Humana during the 3rd quarter valued at $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana in the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP boosted its position in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Finally, LRI Investments LLC grew its stake in shares of Humana by 1,021.4% during the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 143 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HUM has been the topic of several analyst reports. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Piper Sandler boosted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Finally, Morgan Stanley raised their price objective on Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $302.70.

Humana Stock Up 0.7 %

HUM stock opened at $284.74 on Wednesday. The company has a market cap of $34.29 billion, a price-to-earnings ratio of 25.22, a P/E/G ratio of 2.13 and a beta of 0.55. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $411.80. The business has a 50 day moving average price of $273.82 and a two-hundred day moving average price of $306.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Analysts anticipate that Humana Inc. will post 16.11 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.24%. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.29% of the stock is currently owned by corporate insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.